OTLK
Outlook Therapeutics·NASDAQ
--
--(--)
--
--(--)
OTLK fundamentals
Outlook Therapeutics (OTLK) released its earnings on Dec 19, 2025: revenue was -100.00K (YoY --), missed estimates; EPS was -0.06 (YoY +93.18%), beat estimates.
Revenue / YoY
-100.00K
--
EPS / YoY
-0.06
+93.18%
Report date
Dec 19, 2025
Earnings
EPS
Revenue
Revenue & Expenses
OTLK has released its 2026 Q1 earnings report, with revenue of -1.21M, reflecting a YoY change of NaN%, and net profit of -23.06M, showing a YoY change of -232.69%. The Sankey diagram below clearly presents OTLK's revenue sources and cost distribution.
Key Indicators
Outlook Therapeutics (OTLK) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Outlook Therapeutics (OTLK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Outlook Therapeutics (OTLK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Outlook Therapeutics (OTLK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Outlook Therapeutics (OTLK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Outlook Therapeutics (OTLK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Outlook Therapeutics's gross profit margin?What does Outlook Therapeutics do and what are its main business segments?What factors drove the changes in Outlook Therapeutics's revenue and profit?What were the key takeaways from Outlook Therapeutics’s earnings call?What were the key takeaways from Outlook Therapeutics's earnings call?What is the market's earnings forecast for Outlook Therapeutics next quarter?What guidance did Outlook Therapeutics's management provide for the next earnings period?Did Outlook Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
